Language
English
German
^M
Dutch
Spanish
Title:
Gram-Scale Antibody–Drug Conjugate Synthesis by Site-Specific Chemical Conjugation: AJICAP First Generation
Source:
Organic Process Research & development [1083-6160] Matsuda, Yutaka yr:2019
Basic
Full text
Full text available via
American Chemical Society Journals
Year:
Volume:
Issue:
Start Page:
Document delivery
Request document via
Library/Bibliothek
Users interested in this article also expressed an interest in the following:
description
1.
Dickgiesser, S.
"Site-Specific Conjugation of Native Antibodies Using Engineered Microbial Transglutaminases."
Bioconjugate Chemistry
31.4 (2020): 1070-1076.
description
2.
Park, J.
"Site-Specific Antibody Conjugation Strategy to Functionalize Virus-Based Nanoparticles."
Bioconjugate Chemistry
31.5 (2020): 1408-1416.
description
3.
Chen, Y.
"Catcher in the rel: Nanoparticles-antibody conjugate as NF-κB nuclear translocation blocker."
Biomaterials
246 (2020): 119997-119997.
description
4.
Mortensen, Michael R.
"Considerations on probe design for affinity guided protein conjugation."
ChemBioChem
20.21 (2019): 2711-2728.
Select All
Clear All
Save Citations
Select Format
ProCite
EndNote
Reference Manager
RefWorks
Submit citation export
Advanced
Author
Other articles by this author? -- in
GeoRef
author:
Matsuda, Yutaka
Yamada, Kei
Okuzumi, Tatsuya
Mendelsohn, Brian A
last name
initials
Other articles by this author? -- in
Online Contents Geosciences
author:
Matsuda, Yutaka
Yamada, Kei
Okuzumi, Tatsuya
Mendelsohn, Brian A
last name
initials
Other articles by this author? -- using
Web of Science
author:
Matsuda, Yutaka
Yamada, Kei
Okuzumi, Tatsuya
Mendelsohn, Brian A
last name
initials
Web Search
Find related information in
a Web Search Engine
Excite
Google
HotBot
Ixquick
ZOO
Ask
Yahoo!
Bing
Naver
Search Terms:
Search for related information in
Google Scholar
Article Title
Author Name
Journal Title
Other Search
Search Terms:
A service provided by the
Library of the Wissenschaftspark Albert Einstein
, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.